Peter L. Fishman - 01 Mar 2025 Form 4 Insider Report for AMARIN CORP PLC\UK (AMRN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Apr 2025, 07:25:08 UTC
Prior SEC filing
31 Jan 2025
Next SEC filing
04 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jonathan Provoost

Key filing fact

Peter L. Fishman filed Form 4 for AMARIN CORP PLC\UK (AMRN) on 09 Apr 2025.

Key facts

  • This page summarizes Peter L. Fishman's Form 4 filing for AMARIN CORP PLC\UK (AMRN).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 09 Apr 2025, 07:25.

Change

  • Previous filing in this sequence was filed on 31 Jan 2025.
  • Current net transaction value: -$1,118.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMRN transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+2,600
Change %
+3.5%
Price
Shares after
75,984
Date
01 Mar 2025
Ownership
Direct
Footnotes
F1, F2, F3
AMRN transaction

Ordinary Shares

Tax liability

Transaction value
$561
Shares
-891
Change %
-1.2%
Price
$0.6300
Shares after
75,093
Date
01 Mar 2025
Ownership
Direct
Footnotes
F1, F4, F5
AMRN transaction

Ordinary Shares

Options Exercise

Transaction value
Shares
+2,500
Change %
+3.3%
Price
Shares after
77,593
Date
01 Apr 2025
Ownership
Direct
Footnotes
F1, F3, F6
AMRN transaction

Ordinary Shares

Tax liability

Transaction value
$557
Shares
-857
Change %
-1.1%
Price
$0.6500
Shares after
76,736
Date
01 Apr 2025
Ownership
Direct
Footnotes
F1, F4, F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMRN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
+2,600
Change %
Price
$0.000000
Shares after
0
Date
01 Mar 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
2,600
Exercise price
$0.000000
Footnotes
F1, F2, F3, F7
AMRN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
+2,500
Change %
Price
$0.000000
Shares after
2,500
Date
01 Apr 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
2,500
Exercise price
$0.000000
Footnotes
F1, F3, F6, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

On March 1, 2021, the Reporting Person was granted 10,400 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in four equal installments on each of March 1, 2022, March 1, 2023, March 1, 2024, and March 1, 2025.

Footnote F3

Not applicable

Footnote F4

Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.

Footnote F5

Grant price is set at the higher of (1) our nominal par value of 50 pence per share, as converted on date of grant, for which our Plan dictates under United Kingdom law, or (2) fair market value of stock price on the NASDAQ at close of business day.

Footnote F6

On April 1, 2023, the Reporting Person was granted 7,500 RSUs under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in three equal installments on each of April 1, 2024, April 1, 2025, and April 1, 2026.

Footnote F7

Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .